Surmodics, Inc.
Price Action
Technical Summary
WEAKENINGSurmodics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 89), indicating clear outperformance against the broad market. Earnings growth of 30% provides fundamental context to the price action. However, with RSI at 86, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $37.17 | +15.64% | ABOVE |
| 50 SMA | $32.20 | +33.48% | ABOVE |
| 100 SMA | $— | — | |
| 150 SMA | $— | — | |
| 200 SMA | $31.44 | +36.72% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SRDX in an uptrend right now?
SRDX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is SRDX overbought or oversold?
SRDX's RSI (14) is 86. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is SRDX outperforming the market?
SRDX has a Relative Strength (RS) Rating of 89 out of 99. Yes, SRDX is a market leader, outperforming 89% of all stocks over the past 12 months.
Where is SRDX in its 52-week range?
SRDX is trading at $42.98, which is 100% of its 52-week high ($43.00) and 100% above its 52-week low ($25.87).
How volatile is SRDX?
SRDX has a Beta of 0.48 and 52-week volatility of 72%. It's less volatile than the S&P 500 - generally more stable.